Spinal muscular atrophy paediatric - nusinersen or risdiplam - initial authority application form (PB233)

Use this form to apply for initial PBS-subsidised treatment with nusinersen or risdiplam for patients aged 18 years or under with spinal muscular atrophy.

Page last updated: 1 November 2024.
QC 44136